Fredun Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 688.44 million compared to INR 543.51 million a year ago. Revenue was INR 703.23 million compared to INR 547.62 million a year ago. Net income was INR 31.53 million compared to INR 18.4 million a year ago. Basic earnings per share from continuing operations was INR 7.11 compared to INR 4.61 a year ago.
For the six months, sales was INR 1,169.69 million compared to INR 991.7 million a year ago. Revenue was INR 1,187.4 million compared to INR 1,000.12 million a year ago. Net income was INR 40.97 million compared to INR 21.68 million a year ago. Basic earnings per share from continuing operations was INR 10.27 compared to INR 5.43 a year ago.